Dr. Howard Smith Reports

Howard G. Smith MD, AM

Howard G. Smith MD, AM has been reporting health and wellness news for more than 40 years on radio and via podcasts. Harvard Medical School, MD; Harvard University, AM, Immunology; former Medical Editor, WBZ-AM, Boston. Website: http://www.drhowardsmith.com Email: drhowardsmith.reports@gmail.com

  1. 5H AGO

    Heartburn Drugs Could Burn You

    Vidcast:  https://www.instagram.com/p/DVt1yyHGp9p/ Proton pump inhibitors, a popular class of heartburn drugs, may quietly disrupt essential nutrients in the body leading to anemia and bone loss. Environmental and medical researchers from Brazil report their findings in the journal ACS Omega. Their work suggests that long-term use of proton pump inhibitors like omeprazole, pantoprazole, and esomeprazole alters how your body handles key minerals. In this preclinical study, adult rats In the experimental group receiving omeprazole over 10, 30, and 60 days. Controls did not. The results show clear biochemical differences: treated animals have lower iron levels in the blood, consistent with anemia risk, and higher circulating calcium levels, which suggests calcium bone dissolution, osteoporosis. Researchers also document shifts in mineral distribution across organs including the liver and spleen and changes in immune cells. Bottom line: don’t necessarily discontinue these medications, but do avoid long-term, unsupervised use without iron and calcium level monitoring. Your stomach acid plays a critical role in absorbing nutrients like iron and calcium. Though these medications, Prilosec, Protonix and Nexium,  are available over-the-counter as well as with a prescription, it is best to take them with the continuing guidance of your medical team. https://pubs.acs.org/doi/10.1021/acsomega.5c07700  https://www.sciencedaily.com/releases/2026/02/260225081159.htm #heartburn #ppi #iron #calcium #anemia #osteoporosis

    2 min
  2. 5H AGO

    More Rapid Depression Therapy

    Vidcast:  https://www.instagram.com/p/DVt0gRjj4uX/ A treatment for clinical depression that typically lasts six weeks could be compressed into just five days with comparable results. Psychiatrists at the UCLA Health Sciences report this advancement in the Journal of Affective Disorders. This development is an accelerated form of transcranial magnetic stimulation, or TMS. The study included 175 patients. Of those, 40 patients underwent the accelerated “5-by-5” protocol, receiving five sessions a day for five days. The control group of 135 received the standard treatment: one session per day, five days a week, over six weeks. Both groups showed significant reductions in depressive symptoms with no statistically significant difference in overall outcomes. Some patients in the accelerated group demonstrated a delayed effect with depression scores dropping an average of 36% but requiring two to four weeks post treatment. These findings point to a potentially faster, more practical option for those who don’t respond well to antidepressants. A five-day treatment could reduce barriers like time, travel, and work disruption. There is a caveat: this was not a randomized trial, and longer-term outcomes may still favor the traditional schedule. More research is needed before this rapid option is routinely offered to patients. https://www.sciencedirect.com/science/article/abs/pii/S0165032726001965?via=ihub https://www.sciencedaily.com/releases/2026/02/260224023103.htm #depression #tms #magnetism

    2 min

About

Howard G. Smith MD, AM has been reporting health and wellness news for more than 40 years on radio and via podcasts. Harvard Medical School, MD; Harvard University, AM, Immunology; former Medical Editor, WBZ-AM, Boston. Website: http://www.drhowardsmith.com Email: drhowardsmith.reports@gmail.com